BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Black Diamond Therapeutics

Black Diamond Therapeutics logo

Founded
2014
Geography
United States of America based
Funding
$112.100 M

Black Diamond Therapeutics Inc. is a venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.

R&D Platform

The Company’s proprietary technology platform, Mutation-Allostery-Pharmacology, or MAP, platform, is designed to allow Black Diamond to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families and develop a single small molecule therapy in a tumor-agnostic manner that targets a specific family of mutations.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet